{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:21:03Z","timestamp":1794248463765,"version":"4.9.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008196","name":"M\u00e9decins Sans Fronti\u00e8res","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.vaccine.2022.04.093","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T16:24:17Z","timestamp":1654791857000},"page":"4199-4210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study"],"prefix":"10.1016","volume":"40","author":[{"given":"Maria S.","family":"Lightowler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Portia","family":"Manangazira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Nackers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Van Herp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Phiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuziwa","family":"Kuwenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Panunzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Garone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farayi","family":"Marume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Tarupiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Ferreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemence","family":"Duri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Luquero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9973","key":"10.1016\/j.vaccine.2022.04.093_b0005","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0140-6736(13)62708-7","article-title":"Typhoid fever","volume":"385","author":"Wain","year":"2015","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2022.04.093_b0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","author":"Stanaway","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2022.04.093_b0015","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"The Lancet Global Health"},{"issue":"3_Suppl","key":"10.1016\/j.vaccine.2022.04.093_b0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4269\/ajtmh.18-0034","article-title":"Global trends in typhoidal salmonellosis: A systematic review","volume":"99","author":"Als","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"10.1016\/j.vaccine.2022.04.093_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0005786","article-title":"A cross-sectional seroepidemiological survey of typhoid fever in Fiji","volume":"11","author":"Watson","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2022.04.093_b0030","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Heal [Internet]"},{"issue":"2","key":"10.1016\/j.vaccine.2022.04.093_b0035","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.05.020407","article-title":"Systematic review of the global epidemiology, clinical and laboratory profile of enteric fever","volume":"5","author":"Azmatullah","year":"2015","journal-title":"J Glob Health"},{"issue":"12","key":"10.1016\/j.vaccine.2022.04.093_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0114702","article-title":"Descriptive epidemiology of typhoid fever during an epidemic in Harare, Zimbabwe, 2012","volume":"9","author":"Polonsky","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.093_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029119","article-title":"Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: Implications for typhoid vaccine use in Africa","volume":"7","author":"Breiman","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2022.04.093_b0050","first-page":"1","article-title":"Rapid emergence of multidrug resistant, H58-lineage salmonella typhi in blantyre","volume":"9","author":"Feasey","year":"2015","journal-title":"Malawi PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.04.093_b0055","unstructured":"William W. Davis, DrPH1; Prosper Chonzi, MBBS2; Kudzai P.E. Masunda, MBBS2; Lindsey M. Shields, DVM1; Innocent Mukeredzi, MS2; Portia Manangazira, MBBS3; Emmaculate Govore2; Rachael D. Aubert, PhD4; Haley Martin, PhD4; Elizabeth Gonese, PhD5; John B. Ochi M. Notes from the Field: Typhoid Fever Outbreak \u2014 Harare, Zimbabwe, October 2016\u2013March 2017. In: MMWR CDC."},{"key":"10.1016\/j.vaccine.2022.04.093_b0060","unstructured":"IACCH C and TF (Interagency CC on H. Proposal for mass vaccination campaign in response to typhoid outbreak in high-risk Harare suburbs. Harare, Zimbabwe; 2018."},{"issue":"2","key":"10.1016\/j.vaccine.2022.04.093_b0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.15585\/mmwr.mm6802a5","article-title":"Notes from the field: typhoid fever outbreak\u2014Harare, Zimbabwe, October\u20132017 February 2018","volume":"68","author":"N\u2019cho","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.093_b0070","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-4114-0","article-title":"Laboratory characterisation of Salmonella enterica serotype Typhi isolates from Zimbabwe, 2009\u20132017","volume":"19","author":"Mashe","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2022.04.093_b0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, March 2018 \u2013 Recommendations","volume":"37","author":"World Health Organization","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.093_b0080","unstructured":"U.S. Centers for Disease Control and Prevention. 2019 Annual Report CDC Zimbabwe. Harare, Zimbabwe."},{"issue":"37","key":"10.1016\/j.vaccine.2022.04.093_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/1560-7917.ES2013.18.37.20585","article-title":"The test-negative design: Validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials","volume":"18","author":"De Serres","year":"2013","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2022.04.093_b0090","unstructured":"Grimont PAD, Weill F-X. WHO Collaborating Centre for Reference and Research on Salmonella ANTIGENIC FORMULAE OF THE SALMONELLA SEROVARS 2007 9th edition."},{"key":"10.1016\/j.vaccine.2022.04.093_b0095","unstructured":"Wayne P. Clinical and laboratory standards institute (CLSI). In: Performance standards for antimicrobial susceptibility testing 2017 [Internet]. 27th ed. 2017 [cited 2021 Nov 1]. 27 p. Available from: www.clsi.org."},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2022.04.093_b0100","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1093\/cid\/ciy1119","article-title":"The design and analysis of seroefficacy studies for typhoid conjugate vaccines","volume":"68","author":"Liu","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10111","key":"10.1016\/j.vaccine.2022.04.093_b0105","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"The Lancet"},{"issue":"17","key":"10.1016\/j.vaccine.2022.04.093_b0110","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The Efficacy of a Salmonella typhi Vi Conjugate Vaccine in Two-to-Five-Year-Old Children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2022.04.093_b0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cid\/cix1145","article-title":"Seroefficacy of VI polysaccharide\u2013tetanus toxoid typhoid conjugate vaccine (typbar TCV)","volume":"67","author":"Voysey","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2022.04.093_b0120","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"N Engl J Med"},{"issue":"10301","key":"10.1016\/j.vaccine.2022.04.093_b0125","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(21)01124-7","article-title":"Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial","volume":"398","author":"Qadri","year":"2021","journal-title":"The Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2022.04.093_b0130","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1016\/S2214-109X(21)00255-2","article-title":"Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study","volume":"9","author":"Yousafzai","year":"2021","journal-title":"The Lancet Global Health"},{"issue":"12","key":"10.1016\/j.vaccine.2022.04.093_b0135","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa2035916","article-title":"Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children","volume":"385","author":"Patel","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22005527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22005527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:14:37Z","timestamp":1759403677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22005527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":27,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0264410X22005527"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.093","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.03.28.22273032","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}